TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 2282.
Locate Jan Aushadhi KendraClinical Overview
Para Aminobenzoic Acid100mg, Calcium Pant 100mg, Niacinamide12mg, L-Arginine50mg L-Cysteine50mg, DL-Methionine40mg, L-Lysine20mg, Zinc25mg, Inositol 10mg, Biotin10mg, Ferrous10mg, Copper2mg Tablets is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with a full glass of water at scheduled intervals as directed. Complete the full prescribed course.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Localized dryness, mild burning, erythema, pruritus. Rare/Severe: Severe contact dermatitis and systemic hypersensitivity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
For dermatological use as indicated. Discontinue if severe local sensitization or cutaneous allergic reaction develops. Consult dermatologist before use in pregnancy.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Ointment
Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.
Biotin Tablets 10mg
Biotin Tablets 10mg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Finasteride Tablets 5mg
Finasteride Tablets 5mg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Clobetasol Propionate 0.05% and Salicylic Acid 3% Ointment
Clobetasol Propionate (0.05%) and Salicylic Acid (3% or 6%) ointment is a potent keratolytic-corticosteroid combination for hyperkeratotic dermatoses. Clobetasol is an ultra-high potency (Class I) topical corticosteroid that produces rapid vasoconstriction, anti-inflammatory, and immunosuppressive actions, while salicylic acid dissolves the intercellular cement of the stratum corneum, desquamating thick adherent scales and enhancing the penetration of clobetasol into the dermis. Indicated for chronic plaque psoriasis, palmoplantar psoriasis, lichen planus, hypertrophic lichen simplex chronicus, and severe hyperkeratotic eczema.